Trial Profile
Community randomised controlled trial to assess the impact of vaccination with a pneumococcal conjugate vaccine on nasopharyngeal carriage of pneumococci in the Gambia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2013
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms Vilage study
- 13 Jul 2009 New trial record